The α1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily  by Guo, Ying Lan et al.
The K1/2 helical backbone of the prodomains de¢nes the intrinsic
inhibitory speci¢city in the cathepsin L-like cysteine protease subfamily
Ying Lan Guoa, Ursula Kurza, J.E. Schultza, Chin Chia Limb, B. Wiederandersb,
K. Schillingb;*
aFakulta«t fu«r Chemie und Pharmazie, Universita«t Tu«bingen, Morgenstelle 8, D-72076 Tu«bingen, Germany
bInstitut fu«r Biochemie I, Klinikum der Friedrich-Schiller-Universita«t, Nonnenplan 2, D-07740 Jena, Germany
Received 29 November 1999; received in revised form 10 February 2000
Edited by Felix Wieland
Abstract Proregions of papain-like cysteine proteases are
potent and often highly selective inhibitors of their parental
enzymes. The molecular basis of their selectivity is poorly
understood. For two closely related members of the cathepsin L-
like subfamily we established strong selectivity differences. The
propeptide of cathepsin S was observed to inhibit cathepsin L
with a Ki of 0.08 nM, yet cathepsin L propeptide inhibited
cathepsin S only poorly. To identify the respective structural
correlates we engineered chimeric propeptides and compared
their inhibitory specificity with the wild-types. Specificity resided
in the N-terminal part, strongly suggesting that the backbone of
the prodomain was the underlying structure.
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1. Introduction
As papain-like cysteine proteases, cathepsin L and S are
synthesised as proenzymes. The proregions, comprising al-
most one third of the zymogen, are strictly required for ex-
pression of native protease, i.e. for correct folding, stability
and intracellular targeting [1^4]. Their most evident function,
however, is inhibition of the parental enzymes in a pH-depen-
dent manner [5^7]. Fox et al. [8] were the ¢rst to show that a
covalent linkage between the mature part of the enzyme and
the proregion is not essential for this function. A synthetic
peptide consisting of 56 N-terminal residues of procathepsin
B speci¢cally inhibited cathepsin B with a Ki of 0.4 nM,
whereas the Ki for papain was 5.6 WM. Similar results have
been published for members of the cathepsin L-like subfamily,
e.g. papain and cathepsins L and S [9^12]. In each case, the
propeptide binds to the cognate protease with high a⁄nity,
albeit not with absolute speci¢city. Maubach et al. [12] found
that the propeptide of cathepsin S inhibits human cathepsin S
(CS), as well as cathepsins L from human and Paramecium
(CL) with similar potency. On the other hand, the propeptide
of human cathepsin L was shown to be more selective, dis-
criminating cathepsin S by a factor of 500, compared to its
cognate enzyme [10]. The structural basis for this discrimina-
tion has not yet been investigated, albeit it would be impor-
tant for the modulation of the activity of speci¢c cysteine
proteases in biological systems by proregion-derived inhibi-
tors, as suggested by Visal et al. [13].
X-Ray data for the mature cathepsins S and L revealed a
very similar fold [14]. Thus, the selectivity di¡erences in pro-
peptide enzyme interaction of the two cathepsins were attrib-
uted to structural di¡erences between their proregions. Con-
sequently, construction of propeptide chimeras was
considered to be a useful attempt to identify the speci¢city
determining parts of the cathepsin L-like zymogens.
2. Material and methods
2.1. Reagents
Radioisotopes and Sequenase Version 2.0 were from Amersham
Life Sciences, the substrates Z-Phe-Arg-NH-Mec and Z-Val-Val-
Arg-NH-Mec were from Bachem Biochemica, E-64 from Serva. IgA
protease, all restriction enzymes and nucleases were from either Roche
Diagnostics or New England Biolabs. Nylon membranes were ob-
tained from Spectrum Medical Industries. pEV41C was used as the
expression vector. Oligonucleotides were synthesised by MWG-Bio-
tech. Ni-NTA resin was from Qiagen. Preparation of CL, CS and
ppCS was carried out according to Vo«lkel et al. [11] and Maubach
et al. [12], respectively.
2.2. Expression and puri¢cation of recombinant propeptides
The cDNA fragments coding for ppCL and ppCS were ampli¢ed
by PCR. Plasmids containing the proregions of CL [11] and CS
[16] served as templates, the respective sense/antisense primers
were 5PAGGTCGTCATATGAATCTTTATGCAAATTGG/5PATC-
CTCGAGTCACTTGTATTGGAAGTTAG and 5PAGGTCGTCA-
TATGGTGGCACAGTTGCATAAAG/5PATCGTCGACTCATAT-
CCGATTAGGGTTTGAC. PCR cycles (20) were run at 94‡C (50 s),
45^55‡C (depending on the primer pair used; 50 s) and 72‡C (60 s).
Products were digested with NdeI and XhoI or SalI, blunt-ended by
Klenow treatment and inserted into the SmaI site of pEV41C, a heat-
inducible vector fusing a (His)6-tag and an IgA-protease (Igase) di-
gestion site with the N-terminus of the recombinant protein. Fidelity
of all steps was ascertained by sequencing. Using these vectors as
templates, the cDNA segments for the chimeras, speci¢ed in Fig. 1,
were PCR-generated using primer pairs covering the 5P-NcoI or 3P-
EcoRI site in the pEV41C multiple cloning site and the linking boun-
daries, respectively [S/L-chimera: 5PCATCACCACCATGGCCAGC
(vector sequence)/5PCATTCCCATTGAATGCTCCAGG and 5PGC-
CACATTCACTTTGGAATTG/antisense primer for ppCL, above
speci¢ed; L/S-chimeras: ppCL sense primer/5PTTCTTCTGGACTTT-
CATAGAAAGC and 5PCACTCATACGATCTGGGCATG (L1ÿ43/
S55ÿ98) or 5PGGAATGCACTCATACGATC (L1ÿ43/S53ÿ98)/5PGCA-
GAATTCTCATATCCGATTAGGGTTTGAC]. Triple ligation led
to vectors with chimeric inserts. Expression and puri¢cation of the
propeptides was carried out according to Vo«lkel et al. [11], except that
protein was eluted with 300 Wl 50 mM phosphoric acid from the Ni-
NTA-column. The (His)6-tag was cleaved o¡ at an Igase/protein ratio
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of 1:250 at 22‡C in 13 mM potassium phosphate pH 8.0, 80 mM
NaCl, 20 mM KCl, 1 mM EDTA, 1 M urea at 22‡C for 2^3 days.
Due to the Igase speci¢city, all propeptides bear the N-terminal ex-
tension Tyr-Pro. Non-cleaved material was bound to Ni-NTA resin.
Dialysis (1 M NaCl) led to a precipitate which was dissolved in 50
mM phosphoric acid. Yields varied between 0.3^5.5 mg of puri¢ed
propeptides/200 ml culture. Protein concentration was calculated from
A280, using amino acid composition based absorbance coe⁄cients.
The purity and identity of all peptides was assessed by SDS/PAGE
and MALDI-TOF.
2.3. Kinetic measurements
Enzyme activities (kinetic measurements with a LS50B Perkin El-
mer £uorimeter) and dissociation constants (Kd) for the enzyme pro-
peptide complexes (competitive Michaelis^Menten-like model) were
determined according to Kirschke and Wiederanders [15], as modi¢ed
by Maubach et al. [12], at 37‡C. The Michaelis constants (Km), essen-
tial for Kd calculations, are 13.8 and 3.6 WM for the substrates Z-Val-
Val-Arg-NH-Mec (CS) and Z-Phe-Arg-NH-Mec (CL), respectively.
The software ‘PRISM’ (GraphPad) was used for all calculations.
3. Results and discussion
3.1. Inhibition of cathepsins S and L by the recombinant
wild-type propeptides
Tight binding of ppCL and ppCS to their parental enzymes
as well as their lower a⁄nity to papain and to the cathepsins
B and H have been reported [11,12]. To establish reference
values for the purpose of our studies, we ¢rst determined the
kinetic parameters of CL and CS inhibition by the wild-type
propeptides under the experimental conditions. Product
formation (P) as a function of time (t) at inhibitor concen-
trations [I] indicated at the curves (Fig. 2A,B) showed the
typical slow-binding behaviour of high-a⁄nity ligands em-
ployed at very low concentrations. Fitting the data to
P = vst+(vz3vs)(13e3V t)/V led to values for the three parame-
ters: initial velocity (vz), steady-state velocity (vs) and appar-
ent ¢rst-order rate constant for the pre-steady state exponen-
tial phase (V). Plots of the parameter values versus [I] (Fig.
2C,D) revealed the reaction mechanism and the kinetic con-
stants for inhibition [17,18]. The primary data for CL showed
that vz decreased with increasing [I] (Fig. 2A) which indicated
instant inhibition. The initial complex between CL and ppCL
had only moderate stability [initial Kd (Ki ) = 21 nM], which
time-dependently increased by nearly one order of magnitude
[overall Kd (Ki) = 2.6 nM]. Together with the saturation of V
with increasing [I], ensuing from the non-linearity of the re-
spective curve in Fig. 2C (right Y-axis), this indicated a two-
step reaction mechanism, most probably caused by an induced
conformational ¢t of ppCL to a more productive conforma-
tion after its initial binding to the enzyme, as supported by the
¢t of V= f(I) with the equation for this mechanism in Fig. 2C.
The reasons for the initial mis¢t between the inhibitor and its
target were beyond the scope of this investigation; even cer-
tain assay conditions can not be ruled out de¢nitely, e.g. the
temperature may be unphysiological for protozoan proteins.
However, 37‡C was the set measuring the steady state propep-
tide inhibition of the canonical papain and other plant-mem-
bers of the family [19]. Except for papain (Ki = 1.9 nM), all
these constants were higher than our Ki for Paramecium ca-
thepsin L (2.6 nM, Table 1).
In contrast, ppCS instantly inhibited CS with high a⁄nity
(Ki = 0.05 nM; Fig. 2B,D), V was a linear function of [I] and
vz remained nearly constant (Fig. 2D). These results are read-
ily ¢tted by a one-step reaction and agree with those from F
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analogous studies using human cathepsin L (Ki = 0.088 nM)
[10].
Similar inhibition experiments were carried out using ppCS
in conjunction with CL and vice versa (primary data not
shown, Kd values in Table 1). ppCS inhibited CL in a one-
step reaction with about the same kinetics and a⁄nity as its
cognate enzyme (Ki = 0.08 nM). However, ppCL bound CS at
least three orders of magnitude less e¡ective than its cognate
enzyme (Kis 150 nM). Thus, the striking di¡erence in inhib-
itory speci¢city makes these two propeptides ideally suited to
examine the molecular basis of propeptide speci¢city in the
CL-like protease subfamily.
3.2. Inhibition of cathepsin S and L by L/S-propeptide chimeras
Elucidation of the tertiary structures of several cathepsin L-
like proenzymes has demonstrated that all proregions fold to
a compact mini-domain, whose core is de¢ned by the inter-
section point of two longer helices, the N-terminal K1- and the
central K2-helix. The C-terminus of the K2-helix establishes a
hairpin-like structure with the adjacent short L1-strand, the
Fig. 2. Inhibition of the cathepsins L and S by their cognate propeptides. Measurements were performed at 37‡C and pH 6.5 as speci¢ed in
Section 2. Concentrations of the reactants were: (A) 0.25 nM CL, 10 WM Z-Phe-Arg-NH-Mec; (B) 0.05 nM CS, 40 WM Z-Val-Val-Arg-NH-
Mec; and propeptides as indicated. The curves at the primary data level (upper part) correspond to P = vst+(vz3vs)(1*minus;e3 tV )/V as ¢tted
to the respective series of experimental data points. At the secondary data level (lower part), initial (Ki ) and overall (Ki) dissociation constants
were estimated by ¢tting the calculated initial (S) and steady-state (b) velocities, respectively, to v = Vmax[S]/[Km(1+[S]/Km+[I]/Kd)] using the
corresponding Km and [S]. Results are given in Table 1. The left ordinate scales V, the apparent ¢rst-order rate constant for the pre-steady-state
exponential phase (*); the dotted lines correspond to V= f([I]) using the right set of [S], Km and Kd values for the one- and two-step mecha-
nism, respectively: V= koff (1+[I]Km/(Ki(Km+[S]))) and V= koff ((1+([I]/(Ki(1+[S]/Km))))/(1+([I]/(Ki (1+[S]/Km))))) [18].
Table 1
Inhibition of the cathepsins S and L by wild-type and chimeric pro-
peptides, initial (*) and overall dissociation constants
Propeptide Target enzyme
Cathepsin S (nM) Cathepsin L (nM)
WT CS1ÿ98 0.049 þ 0.005 0.079 þ 0.009
WT CL1ÿ86 s 150 20.9 þ 1.5*, 2.6 þ 0.2
S1ÿ54/L44ÿ86 0.1 þ 0.006 1.4 þ 0.08
L1ÿ43/S55ÿ98 s 150 13.6 þ 0.7*
L1ÿ43/S53ÿ98 s 150 not determined
S.D. values as given by the non-linear regression program PRISM.
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super-secondary structure responsible for anchoring and posi-
tioning the proregion at the propeptide binding loop of the
enzyme. A short stretch connects the L1-strand with the very
short K3-helix preceding the extended C-terminus, sterically
preventing substrate access to the active site cleft [20^23].
Although the K1/2 helices of the proregion do not interact
with the enzyme directly they are essential for high-a⁄nity
enzyme binding, as shown for human cathepsin L in inhibi-
tion experiments with a series of truncated propeptides [10].
To investigate their importance for binding speci¢city, we
constructed chimeras in which the K1/2 helices were swapped
between ppCL and ppCS. Considering amino acid alignment
and available structural information, the short band from K2
to L1 was chosen as the linker region to the C-terminal frag-
ment of the proregion, which is in a direct contact to the
enzyme. As the alignment of ppCL and ppCS, given in Fig.
1, revealed in this region two additional amino acids in the
ppCS sequence, we constructed the two L/S chimeras, L1ÿ43/
S55ÿ98 and L1ÿ43/S53ÿ98.
Compared to wild-type ppCS, chimera S1ÿ54/L44ÿ86 inhib-
ited CS and CL with identical kinetics (primary data not
shown) and only somewhat reduced e⁄ciency, quanti¢ed by
the increase of the Ki values from 0.05 to 0.1 nM and 0.08 to
1.4 nM, respectively (Fig. 3 and Table 1). Thus, the N-termi-
nal fragment dominated the binding behaviour of S1ÿ54/
L44ÿ86. Also chimera L1ÿ43/S55ÿ98 behaved more like the do-
nor of the N-terminus, since it inhibited CS only weakly
(Kis 150 nM) and CL with an initial Ki of 13.6 nM, i.e. in
between the initial and steady-state values of CL inhibition by
ppCL (Table 1). We were unable to establish a steady-state Ki
value for this chimera because of a slow time-dependent loss
of inhibitory potency. This could be explained by proteolytic
degradation of the L/S chimera, analogous to the known pH-
dependent ppCS cleavage by CL [12]. The L1ÿ43/S53ÿ98 chi-
mera with the prolonged linker region (additional -GM-),
built to check the in£uence of the above mentioned gap in
the alignment of the wild-type prosequences, did not inhibit
CS with higher a⁄nity than L1ÿ43/S55ÿ98 (Table 1). Conse-
quently, the lack of e¡ective CS inhibition by both L/S chi-
meras could be attributed to the fused fragments itself and not
to their impaired mutual orientation due to an inappropriate
length of the linker region.
4. Conclusions
Our chimeric approach clearly indicates that in the cathep-
sin L-like subfamily the crossed K1/2-helices, establishing the
backbone of the small prodomain, contribute decisively to the
selectivity of propeptide^enzyme interactions. This result ex-
tends the ¢nding by Carmona et al. [10], that N-terminal
truncation of the primary structure of human cathepsin L
propeptide abolishes high-a⁄nity binding to the parental en-
zyme. Discovering the three-dimensional structure of the re-
spective zymogen, Coulombe et al. [20] discussed the surpris-
ing fact that a part of the molecule without any direct contact
to the target strongly determines the binding behaviour. They
discussed that at least the K2-helix may act via conformational
stabilisation of the adjacent structures, L1-stretch and K3-he-
lix, considered to be the principal anchors towards the enzyme
[24]. Recently, evidences for ordered, pH-dependent second-
ary and tertiary structures of the propeptides of the cathepsins
L and S in the absence of the parental enzymes have been
presented [7,25]. This suggests that, at least at about neutral
pH, the K2-helix may not only stabilise but even determine the
position of the two anchor sites. According to Groves et al.
[24], comparing the X-ray data of procathepsin L and procar-
icain, the region £anked by the anchors establishes numerous
speci¢c contacts to the cognate enzymes, probably involved in
speci¢city determination. Because these interactions clearly
are distal to the substrate-binding cleft, the data may open
new perspectives for inhibitor design, too.
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